Media
News and press releases
Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.
Latest pressreleases
Latest News
Cinclus Pharma at the ABGSC – Life Science Summit
Cinclus Pharma participated in the ABGSC Life Science Summit, where CEO Christer Ahlberg presented the recent company updates and the development of linaprazan glurate.
Maria Engström – Ambitious CFO with a passion for development
Maria Engström, CFO at Cinclus Pharma, shares her perspective on driving change and supporting company growth and development.
Christer Ahlberg about the present and the future of Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma since June 2021, shares his thoughts about the company's current position and future vision.
Life Science Sweden interviews Kjell Andersson, CSO
During Life Science Sweden's conference "Pharma Outsourcing", Kjell Andersson, CSO at Cinclus Pharma, was interviewed about our drug candidate linaprazan glurate, which is an acid secretion inhibitor, a so-called P-CAB.
Cinclus Pharma in media
Cinclus Pharma raises a quarter of a billion SEK - EQT founder among investors
2022-05-20|Swedish link] Cinclus Pharma tar in nära en kvarts miljard kronor i en riktad emission inför bolagets stundande börsnotering. Riskkapitalfonden Eir...
Cinclus raises 240 million for Losec follow-up
2022-05-20[Swedish link] Cinclus Pharma tar in cirka 240 miljoner kronor i en nyemission. Målet: att ta fram en uppföljare till magsårsläkemedlen Losec och Nexium...
Telegram: Bengt Julanders Linc invests in Cinclus Pharma
2022-05-20[Swedish link] Forskningsbolaget Cinclus Pharma genomför en kapitalanskaffning där bolaget tar in cirka 240 miljoner ...
Telegram: Cinclus Pharma raises SEK 240 million
2022-05-20[Swedish link] Cinclus Pharma, ett biofarmaceutiskt företag, har rest cirka 240 miljoner kronor genom en riktad nyemission. Syftet är att anskaffa ...
Ståhlberg among investors in stock market candidate that raises a quarter of a billion
2022-05-20[Swedish link] Bioläkemedelsföretaget Cinclus Pharma har genomfört en riktad nyemission på cirka 240 miljoner kronor inför bolagets stundande börsnotering. Bland investerarna syns...
